Original Source(s)
Related Content
Guselkumab Shows Psoriasis Benefit in Darker Skin Tones
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026
-
3 min
FDA Approves Pediatric Risankizumab
Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.
June 29, 2026
-
3 min
Triglycerides Linked to Psoriasis Risk
Genetically predicted triglyceride levels were associated with higher odds of psoriasis, while genetically predicted total fatty acid levels were not, in a two-sample Mendelian randomization analysis.
June 26, 2026
-
4 min